Login / Signup

Early use of angiotensin-converting enzyme inhibitor and β-blocker attenuated doxorubicin-induced cardiomyopathy.

Koji KumeKentaro UenoJunpei KawamuraYasuhiro OkamotoYoshifumi Kawano
Published in: Pediatrics international : official journal of the Japan Pediatric Society (2022)
Keyphrases
  • angiotensin converting enzyme
  • angiotensin ii
  • high glucose
  • diabetic rats
  • heart failure
  • drug delivery
  • cancer therapy
  • stress induced